Radiopharmaceuticals

Closed Solicitation Posted

Solicitation number
W81K0025QA243
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Fort Bliss, Texas 79918, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of the Army Medical Command is procuring radiopharmaceuticals specifically designed for diagnostic and therapeutic purposes for the William Beaumont Army Medical Center's Department of Radiology, Nuclear Medicine section at Fort Bliss, Texas. The solicitation encompasses seven line items of various radiopharmaceuticals including FDG, NaF, Amyvid, Posluma, and Cerianna, along with associated delivery services. This is a firm fixed price procurement with quantities ranging from 1 to 615 units across the different line items. The contract includes both routine and flight delivery options to accommodate the medical facility's operational requirements. The solicitation was posted on September 12, 2025, with responses due by September 16, 2025, providing only a four-day response window.

While the main solicitation notice indicates no set-aside was used, the government file summary reveals this procurement is actually set aside for Women-Owned Small Business (WOSB) enterprises, creating a potential discrepancy in the documentation. The contract performance period extends from the solicitation issue date of September 12, 2025, through September 30, 2026, providing approximately 13 months of service delivery. All radiopharmaceuticals and services will be delivered to the AMC Beaumont Bliss - MM location at Fort Bliss, Texas, with Matt Melendez serving as the designated point of contact. The procurement falls under NAICS code 325412 for Pharmaceutical Preparation Manufacturing and PSC category 6505 for Drugs and Biologicals. No incumbent contractors or specific award values are mentioned in the available documentation.

Notice text

Radio Pharmaceuticals for William Beaumont Army Medical Center, Fort Bliss Texas that are specifically designed to be used for diagnostic and therapeutic purposes in the Department of Radiology, Nuclear Medicine section.

Files

File Type Posted
W81K0025QA243.pdf PDF

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 See Section 11 of the Cleveland and Kent, Ohio, United States · NAICS 325412 Veterans Integrated Service Network 10 No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity